OAMU
TMO icon

Ostrum Asset Management US’s Thermo Fisher Scientific TMO Stock Holding History

Ostrum Asset Management US’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$33M Sell
120,699
-77,372
-39% -$19.3M 9.2% 1
2018
Q4 		$44.3M Buy
+198,071
New +$46.5M 6.54% 4

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ostrum Asset Management US's TMO Position: Q1 2019 in Review

Ostrum Asset Management US reduced its Thermo Fisher Scientific (TMO) stake by 39% in Q1 2019, selling an estimated $19.3M and leaving 120,699 shares worth $33M. The position accounts for 9.2% of the portfolio, ranked #1.

Ostrum Asset Management US first reported a position in TMO in Q4 2018 and has held it in 2 quarters since. The position peaked at $44.3M in Q4 2018. 1,523 funds tracked by Wall St. Rank hold TMO as of Q1 2019.

  • Ostrum Asset Management US held 120,699 shares of Thermo Fisher Scientific worth $33M as of Q1 2019.
  • Ostrum Asset Management US sold 77,372 Thermo Fisher Scientific shares in Q1 2019, an estimated $19.3M.
  • Thermo Fisher Scientific made up 9.2% of Ostrum Asset Management US's portfolio in Q1 2019, its #1 holding.
  • Ostrum Asset Management US first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 2 quarters since.
  • Ostrum Asset Management US's Thermo Fisher Scientific position peaked at $44.3M in Q4 2018.
  • 1,523 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2019.

Based on Ostrum Asset Management US's 13F filing for Q1 2019, filed 15 May 2019.